Ozon Pharmaceuticals

Ozon Pharmaceuticals is a Russian manufacturer of pharmaceuticals. The product range is represented in all pharmaceutical niches: traditional low molecular weight pharmaceuticals, production of highly toxic drugs against oncology and complex science-intensive drugs in the field of biotechnology. It produces more than 350 items of finished pharmaceuticals, with an annual output of about 5 billion units.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Ozon Pharmaceuticals balance sheet

Report period2021 2022 2023 Q3 24
End date of the reporting period
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Ozon Pharmaceuticals cash flows

Report period2021 2022 2023 Q3 24 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Ozon Pharmaceuticals multipliers

Report period2021 2022 2023 Q3 24 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Ozon Pharmaceuticals profitability

Report period2021 2022 2023 Q3 24 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Ozon Pharmaceuticals assets
Ozon Pharmaceuticals cash flows
Ozon Pharmaceuticals dividends
0.55%

Ozon Pharmaceuticals dividend policy

The criterion for dividend payment is the Net Debt / EBITDA ratio. The dividend policy envisages the following scenarios: Net Debt / EBITDA > 3x - no dividends are paid; 2x < Net Debt / EBITDA ≤ 3x - at least 15% of Net Profit; 1x < Net Debt / EBITDA ≤ 2x - at least 25% of Net Profit; 0x < Net Profit / EBITDA ≤ 1x - at least 35% of Net Profit, but not more than 100% of free cash flow; Net Profit / EBITDA = 0x - at least 50% of Net Profit, but not more than 100% of free cash flow.

Ozon Pharmaceuticals shares

TickerNameTypeNominal valueISINPrice
OZPH:RMOzon PharmaceuticalsCommon shareRUB 0.02RU000A109B25RUB 32.9

Ozon Pharmaceuticals bonds

NameIssue sizePriceYield
Ozon 001P-01 (RUB)1,000,000 pcs.89.81%19.33%
Ozon 001P-02 (RUB)700,000 pcs.88.95%18.82%

Ozon Pharmaceuticals expected events

DateTypeNoteSource
26.12.2024 10:00
Dividends
The last day of purchase for receiving dividends RUB 0.18 per common share for 9 month 2024.Pictogram of www.e-disclosure.ru  www.e-disclosure.ru
22.01.2025 10:00
Dividends
Deadline for payment of dividends RUB 0.18 per common share for 9 month 2024.Pictogram of www.e-disclosure.ru  www.e-disclosure.ru
Share capital structure of Ozon Pharmaceuticals
Ozon Pharmaceuticals news
18.12.2024
Shareholders of Ozon Pharmaceuticals approved dividends for 9 months 2024 in the amount of ₽0.18 per ordinary share. The last day of purchase of securities to receive dividends is December 26, 2024. Dividend yield may amount to 0.6%.
Source: {source} pictogram e-disclosure.ru
Pictogram next
18.12.2024
Ozon Pharmaceuticals has received approval from the Ministry of Health to conduct a comparative randomized clinical trial on the pharmacokinetics and safety of the seventh biotech drug. It is intended for the treatment of juvenile arthritis, rheumatoid arthritis, psoriatic arthritis. A total of 28 biosimilars are at different stages of development and regist...
Source: {source} pictogram ozonpharm.ru
Pictogram next
06.12.2024
Ozon Pharmaceuticals introduced Cruoxaban with the active substance Rivaroxaban - a generic of the best-selling foreign drug. Its sales volume for 9 months of 2024 exceeded ₽13 billion. To date, more than 400 thousand packs of the generic have already been shipped.
Source: {source} pictogram ozonpharm.ru
Pictogram next
26.11.2024
Board of Directors of Ozon Pharmaceuticals recommended that dividends be paid for 9 мес. 2024 in the amount of ₽0.18 per ordinary share. The last day of the purchase of securities to receive dividends is December 26, 2024. Dividend yield may amount to 0.64%.
Source: {source} pictogram e-disclosure.ru
Pictogram next
All Ozon Pharmaceuticals news
General information
Company nameOzon Pharmaceuticals
Tags#pharmacy, #biotechnology, #ipo2024
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business addressRF, Samarskaya oblast, g. Zhigulevsk, ul. Gidrostroiteley, d. 6
Mailing address445351, Samarskaya oblast, g. Zhigulevsk, ul. Gidrostroiteley, d. 6
Websiteozonpharm.ru
Information disclosuree-disclosure.ru